Literature DB >> 17066433

Bone primary sarcomas undergone unplanned intralesional procedures - the possibility of limb salvage and their oncologic results.

Dae-Geun Jeon1, Soo-Yong Lee, Jin-Wook Kim.   

Abstract

BACKGROUND: It is quite rare but some primary sarcomas of the bone can be misdiagnosed as benign and be treated using intralesional procedures. An unplanned surgical excision occurs when tumors are removed without the appropriate preoperative evaluation and consideration for the need to obtain tumor-free margins. Residual tumor tissue as a result of unplanned excision of soft tissue sarcoma is a risk factor for local recurrence.
METHODS: Twenty-five patients, undergone unplanned intralesional procedures of lower extremities, were enrolled in this study. There were 22 (88%) cases of osteosarcomas, 2 (8%) MFH of bone and 1 (4%) adamantinoma. Twenty-two (88%) cases had a limb salvage and among them, 4 (18%) cases had local recurrences. Three cases (12%) had amputation without any local event.
RESULTS: Lung metastasis developed in 6 (24%) cases. The CDF 5 year survival for 22 osteosarcoma cases was 65%(confidence interval: 52-82%). DISCUSSION: Despite the high recurrence rate, the CDF survival of osteosarcoma cases was comparable to the primary one. Limb salvage procedures are worthwhile in cases whose initial radiographic findings simulate benign lesions, showing favorable response to neoadjuvant chemotherapy. The relative contraindication to the limb salvage is cases with a history of a pathologic fracture and extensive operative fixation. (c) 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2006        PMID: 17066433     DOI: 10.1002/jso.20607

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  8 in total

1.  Meta-analysis of the prognosis after surgical treatment of osteosarcoma complicated by pathologic fracture.

Authors:  Wei Zhong; Ziyi Wu; Yuhao Yuan; Wei Luo
Journal:  Am J Transl Res       Date:  2022-04-15       Impact factor: 3.940

2.  Standard Treatment Remains the Recommended Approach for Patients with Bone Sarcoma Who Underwent Unplanned Surgery: Report from the Japanese Musculoskeletal Oncology Group.

Authors:  Tomoki Nakamura; Jun Sugaya; Norifumi Naka; Hiroshi Kobayashi; Tomotake Okuma; Toshiyuki Kunisada; Kunihiro Asanuma; Hedetatsu Outani; Shunji Nishimura; Hiroyuki Kawashima; Toru Akiyama; Taketoshi Yasuda; Shinji Miwa; Akihiro Sudo; Takafumi Ueda
Journal:  Cancer Manag Res       Date:  2020-10-12       Impact factor: 3.989

3.  Screening feature genes of osteosarcoma with DNA microarray: a bioinformatic analysis.

Authors:  Yunpeng Zhang; Shi Yan; Daifeng Lu; Feng Dong; Yongyun Lian
Journal:  Int J Clin Exp Med       Date:  2015-05-15

4.  Plain radiologic findings and chronological changes of incipient phase osteosarcoma overlooked by primary physicians.

Authors:  Won Seok Song; Dae-Geun Jeon; Wan Hyeong Cho; Chang-Bae Kong; Sang Hyun Cho; Jung Wook Lee; Soo-Yong Lee
Journal:  Clin Orthop Surg       Date:  2014-05-16

5.  Effect of Unplanned Therapy on the Prognosis of Patients with Extremity Osteosarcoma.

Authors:  Bing Wang; Ming Xu; Kai Zheng; Xiuchun Yu
Journal:  Sci Rep       Date:  2016-12-08       Impact factor: 4.379

Review 6.  Establishing musculoskeletal oncology service in resource constrained country: challenges and solutions.

Authors:  Obada Hasan; Akbar Zubairi; Zohaib Nawaz; Masood Umer
Journal:  Int J Surg Oncol (N Y)       Date:  2017-11-15

7.  Meta-analysis of limb salvage versus amputation for treating high-grade and localized osteosarcoma in patients with pathological fracture.

Authors:  Ke Yin; Qiande Liao; DA Zhong; Jie Ding; Bing Niu; Qiupping Long; Dengfeng Ding
Journal:  Exp Ther Med       Date:  2012-08-28       Impact factor: 2.447

8.  Rotationplasty for Unplanned Fixation of Pathological Fracture Distal Femoral Osteosarcoma.

Authors:  Chindanai Hongsaprabhas; Wittavat Chenboonthai; Phoomchai Suvaraksakul; Chris Charoenlap
Journal:  Case Rep Orthop       Date:  2020-10-27
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.